Natco Pharma Limited (NATCOPHARM) Share Analysis
NSE · Healthcare · Pharmaceuticals
Natco Pharma Limited (NSE: NATCOPHARM) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 100. As of 21 Sep 2026, the share price was ₹813.00, market capitalisation ₹14,569 Cr, P/E 12.7, ROE 17.1%.
Get the AI verdict on NATCOPHARM: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
NATCOPHARM price and valuation
- Share price
- ₹813.00
- Market cap
- ₹14,569 Cr
- P/E ratio
- 12.7
- P/B ratio
- 1.58
- EPS
- ₹63.89
- Book value per share
- ₹515.00
- Dividend yield
- 0.61%
NATCOPHARM profitability and growth
- ROE
- 17.1%
- ROCE
- 17.4%
- Debt to equity
- 0.08
- Revenue growth (3 yr)
- 15%
- Revenue growth (5 yr)
- 15%
- Profit growth (3 yr)
- 27%
- Profit growth (5 yr)
- 28%
NATCOPHARM 52-week range
- 52-week high
- ₹1,226.80
- 52-week low
- ₹789.00
- Face value
- ₹2.00
NATCOPHARM shareholding pattern
- Promoters
- 49.41%
- FIIs
- 16.99%
- DIIs
- 5.63%
- Public
- 27.97%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 100, NIFTY Smallcap 250, NIFTY Smallcap 50.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.